Familiar waters

George Rathmann, chairman, president and CEO of Icos (ICOS), is prepared to make his second personal investment in a biotech limited partnership vehicle. He plans to help Icos Clinical Partners L.P. meet its lofty goal of selling $100 million worth of partnership interests to private investors (see B18).

While the company declined to discuss the deal, citing the quiet period, a spokesperson indicated that Rathmann is likely to participate in

Read the full 705 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE